Showing 1 - 6 of 6
Persistent link: https://www.econbiz.de/10002394517
Persistent link: https://www.econbiz.de/10002397037
Persistent link: https://www.econbiz.de/10002397049
Persistent link: https://www.econbiz.de/10002397087
Persistent link: https://www.econbiz.de/10002397025
Our study suggests that molecular markers can be sensibly combined with clinical guidelines to determine the risk profile of adjuvant breast cancer patients. Compared with the current German best practice (German-S3), combinations of EPclin with the St. Gallen, German-S3 or NCCN guideline and...
Persistent link: https://www.econbiz.de/10011152298